|Bid||330.74 x 1100|
|Ask||344.80 x 1800|
|Day's Range||338.30 - 342.27|
|52 Week Range||224.15 - 415.73|
|Beta (5Y Monthly)||1.07|
|PE Ratio (TTM)||46.06|
|Earnings Date||Feb 14, 2024 - Feb 19, 2024|
|Forward Dividend & Yield||0.80 (0.23%)|
|Ex-Dividend Date||Jan 30, 2024|
|1y Target Est||390.43|
Subscribe to Yahoo Finance Plus to view Fair Value for WST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2024 dividend of $0.20 per share. The dividend will be paid on February 7, 2024, to shareholders of record as of January 31, 2024.
West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device.